Thomas B Smith Insider Profile

4 Followers
Thomas B Smith, CMO at BioDelivery, holds 53.82K shares in Collegium Pharmaceutical (Ticker: COLL), holds 0.00 shares in BioDelivery (Ticker: BDSI). Most recently, Thomas B Smith Sold ― shares of Collegium Pharmaceutical on Sep 17, 2024 for an estimated value of 351.30K.
tipranks
Thomas B Smith

Thomas B Smith
BioDelivery (BDSI)
CMO

Ranked #41,518 out of 99,335 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+13.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Thomas B Smith's holdings

Insider Roles

Collegium Pharmaceutical
(COLL)
EVP and Chief Medical Officer
Roles that Thomas B Smith holds in companies

Most Profitable Insider Trade

Stock:
Collegium Pharmaceutical
(COLL)
Rating:Informative Sell
Date:Sep 17, 2024 - Today
Return:+13.90%
The most profitable trade made by Thomas B Smith

Thomas B Smith's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BDSI
BioDelivery
Mar 22, 2022
Uninformative Sell
$0.00
Collegium Pharmaceutical
Sep 17, 2024
EVP and Chief Medical Officer
Informative Sell
351.30K
$1.73M
List of latest transactions for each holding click on a transaction to see Thomas B Smith's performance on stock

Thomas B Smith insider profile FAQ

What is the percentage of profitable transactions made by Thomas B Smith?
The percentage of profitable transactions made by Thomas B Smith is 100%.
    What is the average return per transaction made by Thomas B Smith?
    The average return per transaction made by Thomas B Smith is 13.50%.
      What stocks does Thomas B Smith hold?
      Thomas B Smith holds: BDSI, COLL stocks.
        What was Thomas B Smith’s latest transaction?
        Thomas B Smith latest transaction was an Informative Sell of $351.30K.
          What was Thomas B Smith's most profitable transaction?
          Thomas B Smith’s most profitable transaction was an Informative Sell of COLL stock on September 17, 2024. The return on the trade was 13.90%.
            What is Thomas B Smith's role in BioDelivery?
            Thomas B Smith's role in BioDelivery is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.